China Oncology ›› 2017, Vol. 27 ›› Issue (12): 928-934.doi: 10.19401/j.cnki.1007-3639.2017.12.002

Previous Articles     Next Articles

Preliminary study on the mapping of internal mammary sentinel lymph node of VX2 rabbit breast cancer using magnetic resonance lymphography

TAN Hongna1,WANG Pange1, LIU Yang2, XIA Yanna2, WANG Bo1, XIAO Huijuan1, GAO Jianbo1   

  1. 1. Department of Radiology, the First Hospital Affiliated to Zhengzhou University, Zhengzhou 450052, Henan Province, China; 2.Department of Radiology, the Fifth Hospital Affiliated Zhengzhou University, Zhengzhou 450052, Henan Province, China
  • Online:2017-12-30 Published:2018-01-11
  • Contact: GAO Jianbo E-mail:cjr.gaojianbo@vip.163.com

Abstract: Background and purpose: Internal mammary lymph node (IMLN) has a similar predictive value of distant metastasis and long-term recurrence as that of axillary lymph node. IMLN can not be removed under modified radical mastectomy, so the blind radiotherapy can sometimes be applied to the patients with suspected metastasis in the internal mammary region clinically. How to select the breast cancer patients who are suitable for IMLN biopsy or resection is an urgent clinical problem. This study aimed to investigate the feasibility of internal mammary sentinel lymph node (SLN) mapping using magnetic resonance lymphography (MR-LG) in VX2 rabbit breast cancer model. Methods: Fifty-five purebred female New Zealand white rabbits were used to establish the model of VX2 rabbit breast cancer, then MR-LG examinations were performed. The raw images were transferred to Philips IntelliSpace Portal (ISP) workstation for post-processing. The first one or several lymph nodes along the lymph duct draining from the injection sites to axilla or internal mammary were defined as SLN. The SLN and draining lymphatic vessels were recorded, then compared with the results of SLN biopsy (SLNB). Results: The success rate of model establishment was 98.2% (54/55), and 51 rabbits were enrolled in this study finally. On MR-LG, compared with the mapping of SLN and lymph ducts immediately after administration of the contrast agent, more internal mammary lymph ducts (36 vs 25, P=0.021) were shown, and more rabbits with both axillary SLN and lymph ducts mapping were detected (45 vs 37, P= 0.040) 5 minutes after administration of the contrast agent. On the internal mammary MR-LG, the long diameter, the short diameter of SLN and the diameter of mapping lymph ducts were (2.64±0.59) mm, (2.24±0.54) mm and 2.18 mm, respectively. The size of tumor and the number of axillary lymph nodes had significantly different effects on the mapping of internal mammary lymph ducts (P=0.032 and 0.040, respectively). Among 15 internal mammary SLNs detected on 11 cancer-bearing rabbits by SLNB, 6 SLNs were located at the 2nd and the 3rd intercostal space, 5 SLNs at the 1st and the 2nd intercostal space, 2 SLNs at the 3rd and the 4th intercostal space, and one SLN at the 10th intercostal space and xiphoid process. On MR-LG, 11 SLNs were detected in 9 cancer-bearing rabbits, and 7 rabbits (77.8%, 7/9) showed the same results on SLNB. Both the long and short diameters of SLNs measured by SLNB were bigger than those of SLNs measured by MR-LG, which showed significant differences (both P<0.05). Conclusion: MR-LG can be used for mapping internal mammary SLN of VX2 rabbit breast cancer. However, the mapping rate should be improved by further study.

Key words: VX2 rabbit breast cancer, Internal mammary lymph node, Sentinel lymph node, MR lymphography